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On The Violation Of Bounds For The
Correlation In Generalized Estimating
Equation Analyses Of Binary Data From
Longitudinal Trials
Justine Shults, Wenguang Sun, Xin Tu, and Jay Amsterdam

Abstract

It is well-known that the correlation among binary outcomes is constrained by the
marginal means, yet approaches such as generalized estimating equations (GEE)
do not check that the constraints for the correlations are satisfied. We explore this
issue for Markovian dependence in the context of a GEE analysis of a clinical
trial that compares Venlafaxine with Lithium in the prevention of major depressive episode. We obtain simplified expressions for the constraints for the logistic
model and the equicorrelated and first-order autoregressive correlation structures.
We then obtain the limiting values of the GEE and quasi-least squares (QLS)
estimates of the correlation parameter when the working structure has been misspecified and prove that misidentification can lead to a severe violation of bounds.
As a result, we suggest that violation of bounds can provide additional evidence in
ruling out application of a particular working correlation structure. For a structure
that is otherwise plausible and results in only a minor violation, we propose an
iterative algorithm that yields an estimate that satifies the constraints. We compare our algorithm with two other approaches for estimation of the correlation
that have been proposed to avoid a violation of bounds and demonstrate that it
estimates the correlation parameter and bivariate probabilities with smaller mean
square error and bias, especially when the correlation is large.
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Summary. It is well-known that the correlation among binary outcomes
is constrained by the marginal means, yet approaches such as generalized
estimating equations (GEE) do not check that the constraints for the correlations are satisfied. We explore this issue for Markovian dependence in the
context of a GEE analysis of a clinical trial that compares Venlafaxine with
Lithium in the prevention of major depressive episode. We obtain simplified
expressions for the constraints for the logistic model and the equicorrelated
and first-order autoregressive correlation structures. We then obtain the
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limiting values of the GEE and quasi-least squares (QLS) estimates of the
correlation parameter when the working structure has been misspecified and
prove that misidentification can lead to a severe violation of bounds. As a
result, we suggest that violation of bounds can provide additional evidence
in ruling out application of a particular working correlation structure. For
a structure that is otherwise plausible and results in only a minor violation, we propose an iterative algorithm that yields an estimate that satisfies
the constraints. We compare our algorithm with two other approaches for
estimation of the correlation that have been proposed to avoid a violation
of bounds and demonstrate that it estimates the correlation parameter and
bivariate probabilities with smaller mean square error and bias, especially
when the correlation is large.
1.

Introduction

1.1 Venlafaxine Study
We consider a generalized estimating equation (GEE) analysis of a clinical trial of a new treatment for Bipolar Type II major depressive episode
(BP II MDE), Venlafaxine. In this study subjects with moderate to severe
depression were randomized in equal numbers to receive either Venlafaxine or
Lithium as treatment for their condition. The primary goal for the analysis
was to compare trends in the occurrence of MDE between treatment conditions. MDE was defined on the basis of having a 17-item Hamilton Rating
Scale for Depression (HAMD17) total score of ≥ 18 and a Clinical Global
Impression of Severity (CGI-S) score ≥ 4. In addition to comparing time
trends between groups, we had a secondary interest in assessing the occurrence of MDE on each of two visits. For example, an effective treatment
2
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for depression might be expected to have an initial meaningful therapeutic
benefit after one month of treatment, which was approximately the time of
the fourth visit on each subject. It was therefore of interest to assess the
expected likelihood of having MDE both at visit four and at the last visit for
each treatment group. If this likelihood was high for one of the conditions,
then this might suggest that this treatment is not effective therapy for BP
II MDE because subjects in this group are tending to fail at two important
measurement occasions: when initial benefit of an effective treatment should
be conferred and at the end of the treatment period.
GEE requires specification of a generalized linear model for the binary
outcome variable and a structured correlation matrix to describe the pattern
of association amongst the repeated measurements Yij on each subject. As
a byproduct, it also provides estimates of the joint probabilities P (Yij =
yij , Yik = yik ) = P (yij , yik ): They can be expressed as the following function
of the expected values E(Yij ) = P (Yij = 1) = Pij , Qij = 1 − Pij , and the
correlation Corr(Yij , Yik ) = Cijk between measurements Yij and Yik , all of
which are estimated in a GEE analysis (Prentice, 1988):
"
P (yij , yik ) =

y
Pijij

1−y
Qij ij

ik
Pikyik Q1−y
ik

#
(yij − Pij ) (yik − Pik )
1 + Cijk p
.
Pij Pik Qij Qik

(1)

Prentice (1988) noted that the estimated correlations must satisfy certain
constraints in order for the probabilities in (1) to be non-negative. In our
analysis of the Venlafaxine trial some constraints were violated. As a result,
some estimated probabilities were negative. For example, if Cijk = α in a
GEE analysis, the expected proportion of subjects treated with Lithium who
3
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will have MDE at visit 8 but not at visit 4 is −0.0031, which is not a valid
estimate.
1.2 Prior Discussion of Violation of Bounds
Violation of bounds for the correlation in analyses of binary data has been
mentioned by many authors, including Prentice (1988), McDonald (1993),
Shults (1996), Joe (Section 7.1, 1997), Diggle et al. (2002, p. 144-145), and
Jung and Ahn (2005). However, there has been some controversy regarding
the likelihood and impact of this potential violation. For example, Rochon
(1998) noted that GEE “ignores these constraints” (for the correlation) and
cautioned that “the practitioner must be aware of these restrictions, particularly at the design stage.” However, he also said this “appears to cause no
difficulty in practice”. In a recent important publication, Chaganty and Joe
(2004) disagree, making the strong claim that “A routine use of the currently
available GEE software could lead to incorrect analysis, because there is no
check on the dependence of the correlation range as a function of covariates.”
However, we note that these authors did not define incorrect analysis and its
rippling effect on other estimates such as the joint probabilities in (1). To
our knowledge no one has explored this issue for the Markovian dependance
model that we consider in this manuscript.
However, some approaches have been suggested that could be used to
overcome a violation of bounds. The simplest is a working independence
approach that implements an identity matrix to describe the pattern of association among observations within a cluster. This has the additional advantage of avoiding bias in estimation of the regression parameter. As pointed
out by Pepe and Anderson (1994), a diagonal correlation structure should be
4
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applied in order to avoid potentially serious bias in the regression parameter,
unless the following sufficient condition can be satisfied for each subject i:

E(Yij | xij ) = E(Yij | xi1 , xi2 , . . . , xini ),

(2)

where xij is the p × 1 vector of covariates measured on subject i at measurement occasion j. This condition is satisfied for the Venlafaxine study under
the assumption that missing data are missing completely at random (MCAR)
because our covariates of interest are external with a defined path, using the
terminology of Kabfleish and Prentice (1980). As a result, the events {xij }
and {xi1 , xi2 , . . . , xini } are identical and (2) is satisfied, e.g. given that a subject is treated with Venlafaxine at measurement occasion one we know the
values of time and treatment status at all other measurement occasions on
this subject. However, if the analysis was modified to include a time-varying
covariate without a fixed path, such as Young Mania Rating (YMR) score (a
score that indicates severity of mania) then (2) could be violated, e.g. the
likelihood that a subject has MDE given that they are not currently manic
could depend on their history of mania as reflected in their YMR score. Based
on an assessment of the reasons for missing values, the MCAR assumption
seemed reasonable for the Venlafaxine study.
Limitations of the working independence model include the potential for a
serious loss in efficiency in estimation of the regression parameter, especially
for time-varying covariates and when the data are highly correlated (Zhao
et al, 1992; Fitzmaurice, 1995; Mancl and Leroux, 1996; Sutradhar and
Das, 2000; and Wang and Carey, 2003). Schildcrout and Heagerty (2005)
explore the bias-efficiency tradeoff associated with choice of different working
5
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correlation structures that include working independence for GEE analysis
of binary data.
Chaganty and Joe (Section 7.0,pages 857-858, 2004) also describe an approach for overcoming the violation of bounds in their study of data with a
multivariate probit distribution. They suggest that an exchangeable structure should be implemented for a “cluster type samples”, while a first-order
autoregressive AR(1) structure should be applied for longitudinal data. The
correlation parameter α could then be estimated with a value α̂r that is close
to zero (for weak dependence), in the range 0.2- 0.3 (for moderate dependence), or in the range 0.4 - 0.7 (for strong dependence), where “small”,
“medium”, and “large” are defined on the basis of descriptive analyses that
include assessment of odds ratios. Alternatively, they suggested that α could
be estimated with the midpoint α̂m of the boundary values for an equicorrelated (exchangeable) structure. The regression parameter is then estimated
by solving the GEE estimating equation evaluated at α̂r or α̂m .
Limitations of this approach include the following. Their suggested ranges
for α were chosen according to values of the latent variable in a multivariate probit distribution. For other situations, e.g. in order to allow α to
exceed 0.70, the ranges must be modified. This process is also somewhat
arbitrary, e.g. which value (midpoint or number within the selected range)
should we select as the final estimate? It is also not as easy to implement as
direct application of GEE and does not consider application of more complex
correlation structures, which they refer to as weight matrices.
Shults (1996) suggested replacing α̂ with the estimated upper (lower)
boundary value if α̂ exceeds (is smaller than) this bound. However, this ap6
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proach does not check if the updated bounds, which are a function of the
updated estimate of the regression parameter, are satisfied. In this manuscript we therefore propose an iterative algorithm that yields estimates of β
and α that do satisfy the constraints for the correlations. We do this using
GEE and for comparison, also implement the method of quasi-least squares
(QLS), an approach in the framework of GEE.
1.3 Other Approaches for analysis
As described in Molenberghs and Verbeke (p. 47, 2005), three useful
classes of models for non-Gaussian data include marginal, conditionally specified, and subject-specific models. See Young et al (2006) for a comparison
of the population average and conditional likelihood approach. Conditional
models have the drawback that interpretations of their parameters are conditional on the value and number of other responses measured within a subject or on a different subject (Diggle et al, 2002). Their application might
therefore be difficult for analysis of the Venlafaxine study, which has a variable number of measurements per subject. If subject-specific parameters
are treated as random effects, it is also important to note that the resultant model will induce a correlation structure on the outcome variable. For
example, see Diggle et al (2002, p.56). As a result, implementation of mixedeffects models could also potentially result in a violation of bounds for the
induced correlations. Our primary analysis involves a comparison of average trends over time between treatment groups, for which a marginal model
is appropriate (p, 141, Diggle et al, 2002). In this manuscript we focus on
application of marginal models with QLS and GEE.

7
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1.4 Outline for Manuscript
In § 2 we give some definitions regarding a violation of bounds and present
simplified expressions for the constraints for a logistic model and two widely
used correlation structures. In § 3 we describe methods, including the Markovian model for dependence; the GEE and QLS approaches; two informal methods for assessment of goodness of fit; and several approaches for adjustment
for violation of bounds. In particular, we provide the stage one QLS estimates when Cij = α in (1) and ni 6= n; these have not been published
elsewhere. In addition, we prove several results regarding the limiting values
of α̂ under misidentification of the working correlation structure. We then
apply these results in § 4, where we describe when a violation of bounds is
more likely to occur. In § 5 we compare several methods for adjustment with
respect to bias and efficiency. In § 6, we describe analysis of the Venlafaxine
study. Finally, in § 7 we discuss our results and provide recommendations
based on our findings.
2.

Model for Analysis and Definitions

2.1 Model for Analysis of Venlafaxine Study
We considered the following logistic model for the mean and variance of
the binary MDE scores Yij measured on subject i at measurement occasion j:
0

E(Yij ) = g −1 (δij ) = Pij and V ar(Yij ) = φ Pij (1 − Pij ), where δij = xij β;
xij is a p × 1 vector of covariates; β is a p × 1 regression parameter; g −1 (γ) =
exp(γ)/(1 + exp(γ)); and scalar parameter φ = 1. For the Venlafaxine study,
δij = β0 + β1 I(V enlaf axine) + β2 visit + β3 I(V enlaf axine) × visit, (3)
0

so xij = (xij1 , xij2 , xij3 , xij4 ), where xij1 = 1; xij2 = I(V enlaf axine),
which equals 1 for subjects treated with Venlafaxine and 0 for subjects
8
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treated with Lithium; xij3 = visit, which takes value 1, 2, . . . , ni for subject i; and xij4 = I(V enlaf axine) × visit, a treatment by visit interaction
term. There were 26 subjects per treatment group, so that i = 1, 2, . . . 52.
The number of measurements per subject ni ranged from 2 to 8, with a mean
of 6.43.
We suspected that the values of MDE on a subject would tend to be
more similar if they were collected more closely together in time. Because
the measurements were approximately equally spaced, we therefore identified the AR(1) structure, for which Corr(Yij , Yik ) = α|j−k| , as the most
biologically plausible correlation structure for this study. However, we also
planned to apply other structures to assess the sensitivity of results to choice
of working structure. These included the equicorrelated (EQC), for which
Corr(Yij , Yik ) = α for j 6= k, and the identity, for which Corr(Yij , Yik ) = 0
for j 6= k.
2.2 Definitions Regarding Bounds for α
Prentice (1988) noted that the probabilities in (1) will be non-negative if
the correlations Corr(Yij , Yik ) satisfy the following constraints:
Loweri (j, k) ≤ Corr(Yij , Yik ) ≤ U pperi (j, k) ∀ i, j and k,
(4)
n
o
where Loweri (j, k) = max − (wij wik )1/2 , − (wij wik )−1/2 , U pperi (j, k) =
n
o
1/2
−1/2
min (wij /wik ) , (wij /wik )
, and wij = Pij (1 − Pij )−1 . Note that the
lower bound for the correlation is always negative, while the upper bound
will take value between 0 and 1.
Suppose we specify a working correlation structure to describe the pattern of association so that Corr(Yij , Yik ) is a function of parameter α. We
then define the feasible region for α with respect to the true binary bounds
9
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(feasible region (TBB)) for this particular structure to be the interval on
which α satisfies all constraints in (4) when the boundary values Loweri (j, k)
and U pperi (j, k) are evaluated at the true value of β. The feasible region
with respect to the estimated binary bounds (feasible region (EBB)) for this
structure is the interval on which α satisfies all constraints in (4) when the
boundary values are evaluated at the estimated value β̂ of β.
For the EQC structure Corr(Yij , Yik ) = α, so that all constraints in (4)
will be satisfied if
max { Loweri (j, k)} ≤ α ≤ min {U pperi (j, k) } .
i,j,k

(5)

i,j,k

For the AR(1) structure, all constraints for the correlations in (4) will be
satisfied if the following is true for all i, j, and k:
Loweri (j, k) ≤ α|j−k| ≤ U pperi (j, k)
which will be true if and only if:
−U pperi (j, k)1/|j−k| ≤ α ≤ U pperi (j, k)1/|j−k| f or all |j − k| even
and
Loweri (j, k)1/|j−k| ≤ α ≤ U pperi (j, k)1/|j−k| f or all |j − k| odd.
All constraints for the correlations will therefore be satisfied for the AR(1)
structure if
n
max { ζeven , ζodd } ≤ α ≤ min
i,j,k

U pperi (j, k)1/|j−k|

o
,

(6)

where
©
ª
ζeven = max −U pperi (j, k)1/|j−k| f or |j − k| even
i,j,k

10
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and
©
ª
ζodd = max Loweri (j, k)1/|j−k| f or |j − k| odd .
i,j,k

We next simplify the bounds for the logistic link function: First, let
δij = x0ij β. Then wij = Pij /(1 − Pij ) = exp(δij ) ⇒ wij × wik = exp(δij +
0

0

δik ) = exp((xij + xik ) β) and wij /wik = exp(δij − δik ) = exp((xij − xik ) β).
Substitution into (5) and (6) and simple arithmetic can then be used to show
that the feasible region (TBB) for the EQC structure for the logistic model
is given by
(LEQC , UEQC ),

(7)

©
ª
0
where LEQC = maxi,j,k −exp(−|(xij + xik ) β)|/2 and
©
ª
0
UEQC = mini,j,k exp(−|(xij − xik ) β)|/2 . In addition, the feasible region
(TBB) for the AR(1) structure for the logistic model is given by
(LAR1 , UAR1 ),

(8)

where LAR1 = max {ζeven , ζodd } ;
n
o
0
ζeven = max −exp(−|(xij − xik ) β)|/(2|j − k|)) f or |j − k| even ;
i,j,k

n

o

0

ζodd = max −exp(−|(xij + xik ) β)|/(2|j − k|)) f or |j − k| odd ;
i,j,k

and

n
o
0
UAR1 = min exp(−|(xij − xik ) β)|/(2|j − k|) .
i,j,k

The feasible regions (EBB) for the EQC and AR(1) structures and the logistic
model are then given by (L̂EQC , ÛEQC ) and (L̂AR1 , ÛAR1 ), respectively, where
these intervals are obtained by evaluating (7) and (8) at β̂.
The upper bound for α depends on both the regression parameter β and
the within subject deviation in covariates; the within subject deviations will
11
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typically be bounded in longitudinal studies. For example, in a one year
study with height on adults as a covariate, within subject change in height
will be less than 12 inches. If all covariates are all cluster specific, then
Pij = Pik ⇒ wij /wik = 1 and U pperi (j, k) = 1 in (4) for all i, j, and k. In
addition, if β = 0 then wij = exp(x0ij β) = 1 ∀ i and j, so that the feasible
region (TBB) will be (−1, 1) for the AR(1) and EQC structures.
An important characteristic of GEE (and QLS) is that β̂ is consistent,
p

even when the working correlation structure is misspecified. Let → denote
convergence in probability. Because the boundary values in (LEQC , UEQC )
p

and (LAR1 , UAR1 ) are functions of β, (L̂EQC , ÛEQC ) → (LEQC , UEQC ) and
p

(L̂AR1 , ÛAR1 ) → (LAR1 , UAR1 ) as m → ∞, even when the working correlation
structure is misspecified. In other words, the boundary values in the feasible
region (TBB) for α for a particular working structure are still estimated
consistently when the working structure is misspecified.
It is also important to define the feasible region with respect to being
positive-definite (feasible region (PD)) as the interval on which α yields a
positive definite matrix. For example, for an n × n EQC structure, the
feasible region (PD) is (−1/(n − 1), 1); for an AR(1) structure the feasible
region (PD) is (−1, 1). We will refer to a value of α as feasible if it falls
within the particular feasible region of interest; otherwise, we say that it is
infeasible. For example α̂ = 1.3 is infeasible (PD). In addition, we will also
refer to an infeasible or feasible estimate (EBB or TBB) as an estimate that
violates or satisfies the binary bounds (EBB or TBB), respectively. We also
note that one type of violation of bounds can occur alone. For example, in
§ 6 α̂GEE for the EQC structure is feasible(PD) but infeasible(EBB); i.e. it
12
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yields a positive-definite estimated correlation matrix, but fails to satisfy the
estimated binary bounds.
3.

Methods

3.1 Approach for Simulating Binary Data
To simulate correlated binary data, we assumed the following Markovian
dependence model for the likelihood of a particular response on subject i
that was discussed by Liu and Liang (1997) and Jung and Ahn (2005):
P (Yi1 = yi1 , · · · , Yin = yin ) = P (Yi1 = yi1 )

n
Y

P (Yij = yij |Yij−1 = yij−1 ).

j=2

(9)
In Appendix A we prove that Markovian dependence coupled with the assumption that Corr(Yij , Yij+1 ) = α ∀i, j does indeed yield a first-order autoregressive AR(1) structure for the responses within each subject, so that
Corr(Yij , Yik ) = α|j−k| . The Markovian model also allows for straightforward
simulation of correlated binary data, that we accomplished according to the
approach based on permutation probabilities of Kang & Jung (2001). All
programs were written in Stata.
3.2 GEE and Quasi-Least Squares
Here we describe GEE and QLS. For implementation of GEE (Liang and
Zeger, 1986) for the EQC and AR(1) structures, we applied the following
moment estimates that were given in Wang and Carey (2003):
Pm P
i=1
k6=j zik zij
Pni 2
α̂GEE−EQC = Pm
i=1 (ni − 1)
j=1 zij
and

(10)

Pm Pni
i=1
α̂GEE−AR1 = P nP
m
ni −1
i=1

j=2 zij zij−1

2
j=2 zij

+

2
1/2(zi1

+

2
zin
i

o.

(11)

13
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For comparison, we also implemented QLS, a two stage procedure in the
framework of GEE that was developed in Chaganty (1997), Shults and Chaganty (1998), and Chaganty and Shults (1999). In stage one QLS alternates
between updating the estimate of β via the GEE estimating equation for β
and updating the estimate of α by solving the stage one estimating equation
for α:
∂
∂α
n
where Zi (β) =

(

m
X

)
©
ª
Zi0 (β) Wi−1 (α) Zi (β) = 0,

(12)

i=1

Yij −Pij
Pij (1−Pij )

o

is the vector of Pearson residuals and Wi (α)

ni ×1

is the working correlation structure for outcomes on subject i. Because the
solution α̂ to (12) is not consistent, stage two of QLS obtains a final estimate
α̂QLS as the solution to the stage two estimating equation for α:
¾¯¯
½
m
X
∂Wi−1 (δ)
¯
Wi (α) ¯
trace
= 0.
¯
∂δ
i=1

(13)

δ=α̂

QLS then obtains the final estimate β̂QLS of β by again solving the GEE
estimating equation for β evaluated at α̂QLS . This process yields an estimate
of β that has the same asymptotic distribution as the GEE estimate β̂GEE .
For the AR(1) structure Shults and Chaganty (1998) showed that the
stage one estimate α̂ can be expressed as:
s
ni
ni
ni
m P
m P
m P
P
P
P
2
2
2
(zij2 + zij−1
)−
(zij2 + zij−1
)
(zij2 − zij−1
)
α̂ =

i=1 j=2

i=1 j=2

2

ni
m P
P

i=1 j=2

,

(14)

zij zij−1

i=1 j=2

while the stage two estimate α̂QLS (Chaganty and Shults, 1999) is given by
α̂QLS−AR1 =

2α̂
.
1 + α̂2

(15)
14
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For the EQC structure, the stage one estimating equation (Shults, 1996)
can be expressed as follows:

X
i:ni >1

Zi0 Zi −

X 1 + α2 (ni − 1)
0
2
2 (Zi (β) ei ) = 0,
(1 + α(ni − 1))
i:ni >1

(16)

where Ini is the identity matrix and ei is a ni × 1 column vector of ones.
Shults (1996) proved that this equation will have a unique solution in the
feasible region (PD) (−1/(nmax − 1), 1) for the EQC structure, where nmax is
the maximum value of {ni , 1 ≤ i ≤ m}. In general, bisection could be used
to obtain a solution; for balanced data, i.e. when ni = n, Chaganty (1997)
obtained an explicit solution. Shults and Morrow (C.3,2002) obtained the
stage two estimate α̂QLS−EQC :

X ni (ni − 1) α
b2 (ni − 1))
b (b
α (ni − 2) + 2) X ni (ni − 1) (1 + α
/
. (17)
2
2
+
α
b
(n
−
1))
+
α
b
(n
−
1))
(1
(1
i
i
i:ni >1
i:ni >1
3.3 Informal Assessment of Goodness of Fit
In our analysis of the Venlafaxine study in § 6 we used the RotnizkyJewell (1990) adequacy criterion as described in Wang and Carey (2004)
to informally compare the fit of several working correlation structures: This
approach is based on the observation that if the working correlation structure
is close to the true structure, the model-based estimate Σ̂m (that assumes
correct specification) and the “sandwich” estimate Σ̂s (that is typically robust
to misspecification) of the covariance matrix of β̂ should be similar, so that
Q = Σ̂−1
m Σ̂s should be close to an identity matrix. In this case the quantities
c1 = trace(Q)/p and c2 = trace(Q2 )/p, where p is the dimension of Q, should
15
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be close to one in value. In addition, d =

P
j

(ej − 1)2 = c2 − 2c1 + 1, where

ej are the eigenvalues of Q, should be close to zero.
In addition, we proposed the following informal goodness of fit statistic
to compare the working structures in the Venlafoxine study:

gof =

1 X
7
8
1 X
1
X
X
X
(Ogjk (a, b) − Egjk (a, b))2
g=o j=1 k=j+1 a=0 b=0

Egjk (a, b)

,

(18)

where Ogjk (a, b) is the observed number of measurements of MDE for subjects in group g (g = 1 for Venlafoxine; g = 0 for Lithium treatment group)
that take value a and b at visits j and k, respectively. The corresponding expected number of measurements Egjk (a, b) = Pgjk (a, b) Ngjk , where Pgjk (a, b)
is the probability of (Yij = a, Yik = b) = (a, b) obtained using (1) with Pij
and Pik ; Pik is the probability of an occurrence of MDE at visit k for a subject in group g (see §2.1); and Ngjk = 0gjk (0, 0)+ 0gjk (1, 0) + 0gjk (0, 1) +
0gjk (1, 1). The statistic gof is the sum of the 56 Chi-Square goodness of fit
statistics for the bivariate distributions of MDE at visits j and k for subjects
in both treatment groups. Because assumption of a model for the marginal
means and working correlation structure of binary outcomes in a GEE (or
QLS) analysis induces these joint distributions, it is reasonable to compare
the working structures with regard to their ability to yield a model with reasonable fit. Our additional informal assessment therefore identifies the best
structure as the one amongst the candidate structures that minimizes the
gof statistic.
3.4 Asymptotic Violation of Bounds
When the correlation structure is misidentified the bounds (TBB) will be
estimated consistently (see §2.2); however, α̂ may fail to be consistent (Crow16
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der, 1995). In these situations, the bounds (TBB) for a particular working
correlation structure can be violated asymptotically. For convenience, we
use α and ρ to denote the working and true correlation parameter when the
correlation structure is misspecified.
For example, suppose the true structure is AR(1) with parameters ρA
and ρB for subjects in groups A and B, respectively; we correctly specified
the AR(1) working structure, but incorrectly assumed that the correlation is
constant between groups. In this situation, we prove in part (i) of Appendix
p

B that for both QLS and GEE, α̂ −→ wA ρA +wB ρB = lim(ρA , ρB ), where wA
is the proportion of subjects in group A. Suppose the feasible region (TBB)
is (LAR1 (A), UAR1 (A)) for ρA and is (LAR1 (B), UAR1 (B)) for ρB . The feasible
region (TBB) for the AR(1) structure under the assumption that ρA = ρB =
ρ is then given by (LAR1 , UAR1 ), where LAR1 = max {LAR1 (A), LAR1 (B)}
and UAR1 = min {UAR1 (A), UAR1 (B)} . The bounds (TBB) for the AR(1)
structure will not be misspecified asymptotically for this misspecification
scenario, if LAR1 ≤ lim(ρA , ρB ) ≤ UAR1 ; otherwise, the bounds will be
violated asymptotically.
Next, suppose that the working AR(1) structure was misspecified as EQC.
p

In part (ii) of Appendix B we prove that α̂QLS−EQC −→ lim(ρ) in this situation, where lim(ρ) can be obtained using the algorithm given in Appendix
B when ni 6= n, or (B.7) when ni = n ∀ i. When ni = n∀ i we also prove that
the limiting values for α̂ are identical for QLS and GEE; however, they will
not agree for unbalanced data. The bounds (TBB) for the EQC structure
in (7) will not be violated asymptotically for this misspecification scenario,
if LEQC ≤ lim(ρ) ≤ UEQC ; otherwise, the bounds will be violated asymp17
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totically. (Note that if the EQC structure is misspecified as AR(1) then
α̂QLS−EQC (Chaganty and Shults, 1999) and α̂GEE−EQC (Wang and Carey,
2003) will be consistent.)
In an analysis, we will say that the degree of violation of bounds is severe
if the distance between α̂ and the relevant estimated bound is large, e.g. if
p

α̂ − ÛEQC is large. Because β̂ −→ β, even when the correlation structure
p

p

is misspecified, (see § 2.2) ÛEQC −→ UEQC , so that α̂ − ÛEQC −→ lim(ρ) −
UEQC . In § 6, we obtained jackknife confidence intervals for α̂ − ÛEQC . If the
confidence interval did not include zero this suggested that the violation of
bounds was severe, so that the EQC structure may have been misspecified.
3.5 Methods for Estimation of α
In simulations we implemented the following methods for estimation of
α that were discussed in § 1.2: (i) Working Independence Approach: Let
α̂ = 0; (ii) Midpoint Approach: Let α̂ = α̂m where α̂m is the midpoint of
the feasible region (EBB), (L̂EQC , ÛEQC ), when L̂EQC and ÛEQC in (7) are
estimated using GEE (or QLS) with an independence working structure;
and (iii) Iterative Algorithm: In Appendix C we propose a simple iterative
algorithm that can be implemented when the QLS or GEE estimate of α
is infeasible (EBB) for a particular working correlation structure. It is also
easily modified to allow the correlation parameter to vary between groups.
This algorithm will iterate between obtaining an adjusted estimate for α and
updating the estimate for β (by solving the GEE estimating equation for β)
until the bounds for α are satisfied and the current estimate for α is within a
pre-specified distance (tolerance level) from the previous estimate. As noted
in § 1.2, iteration is needed because replacing an infeasible α̂ with ÛEQC ,
18
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for example, may yield an updated β̂ and corresponding updated boundary
values that are not satisfied. Please see §7 for our general recommendations
regarding when adjustment for violation of bounds (EBB) should be done.
3.6 Asymptotic Bias in Estimation of Joint Probabilities
p

Suppose that α̂ −→ f (ρ), where ρ is the true correlation parameter, and
p

that β̂ −→ β. Then if the true correlation structure is AR(1) the asymptotic
bias in estimation of the bivariate probabilities in (1) is given by:
"
#
¡
¢
(y
−
P
)
(y
−
P
)
y
1−y
ij
ik
ik
p ij ik
Cijk (f (ρ)) − ρ|j−k| Pijij Qij ij Pikyik Q1−y
, (19)
ik
Pij Pik Qij Qik
where Cijk (γ) = γ or Cijk (γ) = γ |j−k| if the working correlation structures
are EQC or AR(1), respectively. Note that f (ρ) = 0 for the independence
approach and f (ρ) = (LEQC + UEQC )/2 for the midpoint approach, where
(LEQC , UEQC ) are given in (7).
4.

Conditions Under Which Violation is Likely to Occur

In this section, we assume that β is equal to its estimated value for QLS
and the AR(1) working structure in analysis of Venlafaxine (Table 2).
4.1 When the Working Structure is Correctly Specified
If the correlation structure is correctly specified as AR(1), then violation
of bounds is more likely to occur when α is close to one of the boundary values
in the feasible region (TBB) (LAR1 , UAR1 ) given in (8). Figure 1 displays
the proportion of 200 simulation runs that yielded infeasible (EBB) GEE
estimates of α for ni = 3 ∀ i (left) and ni = 8 ∀ i (right), several group sizes
m, and true values of α in its feasible region (TBB). The graphs for QLS were
very similar (not shown). Figure 1 shows that the likelihood of obtaining an
infeasible estimate (EBB) is high when α is very close to a boundary of the
19
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feasible region and when the sample size is smaller. However, when α was
close to the midpoint of the bounds and for larger sample sizes, infeasibility
(EBB) was less likely to occur.
We also note that although the likelihood of violation (EBB) was high
when α was close to the boundary, the severity of violation (see § 3.4) decreased rapidly with increasing sample size. For example, for α = 0.75 and
ni = 8 ∀ i the (5th , 95th ) percentiles of α̂QLS−AR1 − ÛAR1 (calculated over
runs that resulted in a violation of bounds) for m = 10 versus m = 80 were
(0.003, 0.312) and (0.001, 0.039), respectively. Asymptotically, α̂ will be feasible (TBB) because as discussed in §2.2, if the working correlation structure
is correctly specified, both α and the boundary values in (LAR1 , UAR1 ) will
be estimated consistently. The results were very similar for other values of
m and β, e.g. see Shults et. al (2005).
[Figure 1 about here.]
4.2 When the Working Correlation Structure is Misspecified
As discussed in § 3.4, if the correlation structure is misspecified, the feasible region (TBB) (for α) will be estimated consistently, but α̂ may fail to be
consistent. As in § 3.4, α represents the working correlation parameter and
ρ represents the true parameter when the structure is misspecified.

4.2.1

When α is Incorrectly Assumed to be Constant

Here we assume

that the correlation structure is AR(1), but we have incorrectly assumed
that the working correlation parameter α is constant when it actually takes
values ρV and ρL for subjects in the equally sized Venlafoxine and Lithium
groups, respectively. Using (8) the feasible region (TBB) is (-0.3555,0.8926)
20
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for ρL and is (-0.0674,0.7740) for ρV when ni = 8 ∀ i. The feasible region
(TBB) for the AR(1) structure under the assumption that ρL = ρV = ρ is
T
then given by (−0.3555, 0.8926) (−0.0674, 0.7740) = (−0.0674, 0.7740). If
ρL = 0.85 and ρV = 0.72 then using Appendix B ((i)), the limiting value
of α̂QLS for QLS under an incorrect assumption of constant α is equal to
wL 0.85 + wV 0.72 = 0.5 × 0.85 + 0.5 × 0.72 = 0.785, where wL = wV =
0.5 are the proportion of subjects in the Lithium and Venlafoxine groups,
respectively. If ρV > 0.698, then the limiting value of α̂QLS will exceed 0.774.
As a result, the feasible region (TBB) will be violated asymptotically when
ρL = 0.85 and ρV > 0.698. Figure 2 displays the proportion of infeasible
(EBB ) estimates for this example, when ρL = 0.85 and for several values of
ρV over its feasible region (TBB), when QLS is applied under the incorrect
assumption that the correlation is constant between groups. This graph
displays a vertical line at ρV = 0.698. As expected, when the limiting value
of α̂QLS exceeds 0.774 (when ρV > 0.698) we see higher rates of infeasibility
as the sample size increases, in contrast to the lower rates we observe when
the limiting value is within bounds. (The graphs for GEE are similar and are
not shown.) Results for other values of β (Shults et al., 2005) were similar.
[Figure 2 about here.]

4.2.2

When the AR(1) Structure is Misspecified as EQC

Here we as-

sume that the true correlation structure is AR(1) but has been misspecified
as EQC. As in § 4.2.1 we assume the true value of β equals its estimated
value for the AR(1) structure for QLS in the Venlafoxine study (Table 2).
Using (7) and (8) the bounds (TBB) for the EQC and AR(1) structures are
21
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(LEQC , UEQC ) = (−.0674, .1665) and (LAR1 , UAR1 ) = (−.0674, .7740).
As discussed in § 2.2, even if the true AR(1) structure is misspecified as
p

EQC, (L̂EQC , ÛEQC ) −→ (LEQC , UEQC ). However, α̂QLS−EQC and α̂GEE−EQC
will not be consistent. Figure 3 displays a graph of the limiting value of
α̂QLS−EQC versus the true value of ρ when the true structure is AR(1); ρ takes
values in the feasible region (TBB) (LAR1 , UAR1 ) = (−.0674, .7740) for the
AR(1) structure. The limiting values for QLS were obtained using the algorithm in (ii) of Appendix B; they depend on ni , which took these values in the
Venlafoxine study: ni (number of subjects): 2 (2),3(7),4(2),5(5),6(5),7(4),and
8(27). Figure 3 also displays a horizontal line at the upper value for the
bounds (TBB) for the EQC structure, UEQC = 0.1665.
Figure 3 shows that when the AR(1) structure is misspecified as EQC, the
limiting value for α̂QLS−EQC can be considerably larger than UEQC = 0.1665.
For example, if ρ = 0.7, the asymptotic violation of bounds (see § 3.4) might
be considered severe because
p

α̂QLS−EQC − ÛEQC −→ 0.4376 − 0.1665 = 0.2711.
[Figure 3 about here.]
5.

Comparison of Different Methods of Adjustment

To assess estimation in small samples, we simulated data with Markovian dependence and β equal to its estimated value for the AR(1) structure and QLS (Table 2). Table 1 displays the mean square error (MSE
1000
1000
X
X
= 1/1000
(α̂r − αr )2 ) and bias (BIAS = 1/1000
(α̂r − αr )) based on
r=1

r=1

1000 simulation runs for GEE, QLS, the working independence approach
(IND), and midpoint approach (MID)(see § 3.5). For GEE and QLS, we
22
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implemented the algorithm in Appendix C for estimation of α if the initial
unadjusted estimates were infeasible (EBB). Because the methods only differ
with regard to estimation of α, we displayed simulation results for α̂ with a
working AR(1) structure. (This was primarily for comparison of GEE, QLS,
and the midpoint approach because α̂ = 0 for the independence approach,
so that its bias and mean square error for estimation of α are known.) In
addition, because they were of interest in the Venlafaxine study, we also obtained the MSE and bias for the joint probabilities P (Yi4 = 1, Yi8 = 1)L for
subjects treated with Lithium.
Table 1 shows that application of MID or IND can result in biased and
inefficient estimation of α and of P (Yi4 = 1, Yi8 = 1)L for small samples.
For example, when α = 0.75 and m = 20, (i) the bias and MSE of α̂
were −0.7070 and 0.5003 for the midpoint approach, versus −0.0192 and
0.0030 for GEE; and (ii) the bias and MSE of P̂ (Yi4 = 1, Yi8 = 1)L were
−0.0615 and 0.0072 for the midpoint approach, versus −0.0021 and 0.0047
for GEE. Results were very similar for the midpoint and working independence approach because α̂mid ≈ 0. In addition, results were very similar
p

for QLS and GEE. Asymptotically, (see § 3.6), α̂mid −→ (LEQC + UEQC )/2
= (−0.0674 + 0.1665)/2 = 0.0496. The asymptotic bias for estimation of
α with the midpoint approach is therefore −0.5504 when α = 0.60 and is
−0.7004 when α = 0.75. The asymptotic bias for estimation of the joint
probabilities with the working independence and midpoint approaches (see
§ 3.6) were −0.0275 and −0.0672 when α = 0.60 and α = 0.75, respectively.
These asymptotic values are similar to the estimates in Table 1 for the largest
sample size m = 80.
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Hosted by The Berkeley Electronic Press

[Table 1 about here.]
6.

Analysis of Venlafaxine Study

Table 2 displays the results of the analysis of the Venlafaxine study, for
the model given in §2.1. The feasible regions (EBB) for the EQC and AR(1)
structures were obtained using (7) and (8) evaluated at β̂, respectively. The
informally measured goodness of fit statistics gof and (c1 , c2 , c3 ) were obtained
using (18) and expressions given in § 3.3, respectively.
The GEE and QLS estimates α̂GEE and α̂QLS were infeasible (EBB) (see
§ 2.2) but were feasible (PD) for the EQC structure. The degree of violation of
bounds (see § 3.4) might be considered severe because the 95 percent jackknife
confidence interval (CI) for α − UEQC did not include zero for either approach:
α̂GEE − UEQC = 0.2327 (CI = (0.227, 0.233)) and α̂QLS − UEQC = 0.2503 (CI
= (0.244, 0.251)). (The limiting value of α̂ is not the same for QLS and GEE
when the working structure is misspecified as EQC and ni 6= n∀i. As a result
it is not surprising that the confidence intervals did not overlap for QLS and
GEE.)
As discussed in §1, it was of secondary interest to compare the likelihood of MDE at visits 4 and 8 for the Venlafaxine versus Lithium treatment
groups. The violation of bounds (EBB) for the EQC structure would complicate this assessment because it results in an invalid bivariate distribution
for MDE at these visits, i.e. some of the estimates of P (Yi4 = 1, Yi8 = 1),
P (Yi4 = 1, Yi8 = 0), P (Yi4 = 0, Yi8 = 1), P (Yi4 = 1, Yi8 = 1) (calculated using (3) to calculate the Pij and (1) to calculate the bivariate probabilities) were negative. For example, the GEE estimate for Venlafaxine
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P̂ (Yi4 = 0, Yi8 = 1)V en = −0.0044. (For brevity, Table 2 only displays one
of the four estimated probabilities for each treatment group.)
To assess the sensitivity of results to choice of working correlation structure, we implemented the algorithm in Appendix C to obtain a feasible estimate α̂ (EBB) for the EQC structure. This required 17 iterations. The
adjusted estimates for the (i) regression coefficients were β̂0 = 0.6885 (p =
0.109); β̂1 = 0.2262 (p = 0.707), β̂2 = −0.2575 (p = 0.005); β̂3 = −0.2329
(p = 0.170); (ii) bounds (EBB) were (L̂EQC , ÛEQC ) = (−0.0631, 0.1797);
and (iii) correlation parameter was α̂ = 0.1797. The gof statistic was not
available for the unadjusted EQC structure; for the adjusted analysis the
value of the statistic was 186.3245. The Rotnizky-Jewell informal goodness
of fit statistics (c1 , c2 , d) were (1.7241, 3.3636, 0.9153).
The analysis results differed according to choice of working structure.
For example, results based on application of the AR(1) structure might be
more suggestive of a difference between treatment groups with regard to
time trends in the likelihood of occurrence of MDE. Although the interaction
between time and treatment group was not significant at the 0.05 level for any
structure, the estimated regression coefficient βˆ3 for the interaction term was
significant for the AR(1) structure at a 0.10 significance level. In addition,
βˆ3 was greatest in absolute value for the AR(1) structure (βˆ3 = −0.2850 for
QLS and GEE versus −0.2329 for the adjusted EQC structure and −0.2469
for an identity structure).
In the secondary analysis of occurrence of MDE at visits four and eight,
the differences between structures was striking. (For illustration, we based
estimates of these probabilities on their estimated regression coefficients in
25
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Table 2, irrespective of the corresponding p-values.) For example, the joint
probabilities of MDE at visits four and eight for the Venlafaxine versus
Lithium treatment groups, respectively, were 0.0289 and 0.1197 for the EQC
structure (adjusted estimate); 0.0246 and 0.1283 for the AR(1) structure and
GEE; 0.0245 and 0.1282 for the AR(1) structure and QLS; and 0.0145 and
0.0954 for the identity structure. This resulted in an estimated odds-ratio for
having MDE at visits one of four for Lithium versus Venlafaxine of 5.8403
and 5.8475 for the AR(1) structure with GEE and QLS, respectively; 4.5658
for the EQC structure; and of 7.1735 for the identity structure. As discussed in §3.6 the joint probabilities will be estimated with asymptotic bias
if the working structure is misspecified, so that it is not surprising that these
estimates varied according to choice of working structure.
For our final choice of working correlation structure, we ruled out the
EQC structure for the following reasons: (i) The fit for this structure, as
assessed using the Rotnizky-Jewel informal assessment (see §3.3) was relatively poor; e.g. (c1 , c2 , d) should be close to (1, 1, 0) for good fit, but was
(1.7241, 3.3635, 0.9153) for the EQC structure (with adjusted approach) versus (1.1712, 1.5886, 0.2461) for the AR(1) structure (with GEE). In addition,
the informally measured gof statistics was larger for this structure; e.g. gof
= 186.32 for the EQC structure versus gof = 159.12 for the AR(1) structure
with GEE; (ii) This structure was not identified a priori as the most biologically plausible structure, as discussed in §2.1; and (iii) There was a severe
violation of bounds (EBB) for this structure, as noted earlier in this section.
We also ruled out application of the identity structure because, although
there can be no violation of bounds for this structure, it was not biologically
26
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plausible and had poor fit, e.g. with (c1 , c2 , d) = (2.5723, 8.2379, 4.0933) and
gof = 313.88. We therefore based our results for analysis on the AR(1) working structure which had the best fit, was most biologically plausible, and had
no violation of bounds for α̂.
[Table 2 about here.]
7.

Conclusions and Recommendations

We discussed the potential for violation of bounds for the correlation in GEE
and QLS analysis of correlated binary data in the context of a longitudinal
clinical trial that compared Venlafaxine with Lithium. We demonstrated
that violation is more likely to occur for smaller samples, when α is close to
the boundary value for the feasible region (TBB), and when the correlation
structure is misspecified. For example, we proved that the limiting value of
α̂ can exceed the upper bound UAR1 in (8) if the parameter α in the AR(1)
structure is incorrectly assumed to be equal across groups. In addition, if
the true AR(1) structure is misspecified as EQC and α is large, then we
proved that the limiting value of α̂ can be substantially greater than the
upper bound UEQC for α in (7) for the EQC working structure.
That a severe violation of bounds can result from an incorrect choice
of working structure suggests that following descriptive analyses, the initial
implementation of GEE should not automatically force the bounds on α to
be satisfied. We suggest that the initial analyses should involve application
of traditional (unadjusted) GEE or QLS, with a working structure that was
chosen on the basis of biological plausibility; other simple structures could
also be applied in order to assess the sensitivity of the analysis results to the
choice of working structure. If we anticipate that the degree of association
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depends on group membership in a longitudinal trial, we might allow α̂ to
depend on group membership, e.g. as in Shults and Morrow (2002) who
anticipated that the correlation would vary between control and treatment
groups in an educational intervention to promote exclusive breast-feeding
among lactating women in Mexico. Next, the feasible region (EBB) for α
should be evaluated at β̂ and α̂. If α̂ if infeasible (EBB) and the degree of
violation is severe for a particular structure then this should be taken into
consideration along with other criteria regarding suitability of this structure.
For example, in our analysis of Venlafaxine, there was a severe violation of
bounds for the EQC structure, which was less biologically plausible than
the AR(1) structure and had worse fit according to the informally measured
Rotnizky-Jewell criterion and the informal statistics based on the bivariate
distributions. In addition, the 95 percent jackknife confidence interval for
α − UEQC did not contain zero (see § 6.0). This severe violation of bounds
provided additional evidence in support of ruling out the EQC structure as
the final working structure in this analysis.
If there is a minor violation of bounds for a structure that is biologically
appropriate and has reasonable fit, we suggest that an adjusted estimate of α
could be obtained that is feasible (EBB). This will be necessary if estimation
of the joint probabilities is of interest; otherwise, some estimated probabilities will be negative. If α̂ is infeasible (EBB), we suggest that an adjusted
estimate of α could be obtained using the iterative algorithm in Appendix C.
After several iterations this will yield an estimate that is close the boundary
value (EBB) for the specified working structure. We believe that this is a
reasonable approach because (see § 4.1) violation of bounds is likely when α
28

http://biostats.bepress.com/upennbiostat/art8

is close to the boundary, and is unlikely otherwise. If we apply the working
independence or midpoint approach (see § 5) we demonstrated that this can
result in biased and inefficient estimation of α and of the bivariate probabilities. We also note that our algorithm could be applied after implementation
of other approaches that alternate between estimation of the regression and
correlation parameters, e.g. the GEE1 approach of Prentice (1988).
Although estimation of bivariate probabilities is typically not a primary
goal of GEE analyses, estimates of these probabilities can always be obtained
as a by-product of GEE analysis, because specification of the marginal means
and first order correlations completely determines the bivariate distributions
of the binary outcomes (Prentice, 1988). Their estimation was helpful in the
Venlafaxine trial because the estimated odds-ratio based on the estimated
joint probabilities for having MDE at two important treatment occasions
(visits 4 and 8) was 5.8453 (with the AR(1) structure) which was suggestive
of a strong treatment benefit with Venlafaxine. An analysis that includes
assessment of joint probabilities with the primary comparison of trends over
time might therefore be more encouraging with regard to conducting future
research into the potential benefits of treatment with Venlafaxine.
Additional future research might include describing the correlation structures that are implicitly assumed under assumption of some complex mixed
models and then studying the potential for violation of bounds for these
models. In addition, obtaining the limiting values of α̂ under other misspecification scenarios would be of interest, as would continuation of development
of methods for choosing between several plausible correlation structures.
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Appendix A
Proof that Markov Dependence Coupled with the Assumption that
Corr(yij , yij+1 ) = ρ ∀ i, j yields Data with an AR(1) Correlation Structure
This is easily shown using induction. First, we can use direct calculation to
show that
P (yij = 1, yij+2 = 1) =

X

P (yij = 1, yij+1 = oij+1 , yij+2 = 1)

oij+1 ∈{0,1}

√
= ρ2 pij qij pij+2 qij+2 + pij pij+2 ,
so that Corr(yij , yij+2 ) = ρ2 . Next, if we assume that Corr(yij , yij+k ) =

33

Hosted by The Berkeley Electronic Press

ρk , we can again use direct calculations to show that
X

P (yij = 1, yij+k+1 = 1) =

P (yij = 1, yij+k = oij+k , yij+k+1 = 1)

oij+k ∈{0,1}

√
= ρk+1 pij qij pij+k+1 qij+k+1 + pij pij+k+1
so that Corr(yij , yij+k+1 ) = ρk+1 .

Appendix B
Limiting value of α̂ when the Working Correlation Structure is Misspecified.
We assume the working correlation structure for subject i is Wi (α) and the
true structure is Ri (ρ), where Wi (α) 6= Ri (ρ). Let sg equal the number of
subjects with ng measurements, so that s1 + s2 + . . . sG = m. We also assume
that si /m = wi is fixed so that min {si : i = 1, · · · , G} goes to infinity as m
goes to infinity. In addition, we assume that Wi (α) = Wg (α) and Ri (ρ) =
Rg (ρ) when subject i is in group g; i.e. when ni = sg . We first need to prove
m
m
P
P
p
0
∂
∂
Wi−1 (α)Zi (β)Zi (β) −→ φ m1 ∂α
Wi−1 (α)Ri (ρ), as m → ∞. To
that m1 ∂α
i=1

i=1

0

do this note that since sg → ∞ as m → ∞ and E(Zi (β)Zi (β)) = φRg (ρ) for
m
P
0
∂
subject i in group g, if follows that limm→∞ m1 ∂α
Wi−1 (α) Zi (β) Zi (β)
i=1

G
X
sg ∂
1
Wg−1 (α)
= lim
m→∞
m ∂α
sg
g=1

=

G
X
g=1

wg

1
∂
Wg−1 (α) lim
sg →∞ sg
∂α

=

G
X
g=1

wg

X

0

Zi (β)Zi (β)

i in group g

X

0

Zi (β)Zi (β)

i in group g

∂
W −1 (α) φ Rg (ρ)
∂α g
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G
X
=φ
g=1

X

1 ∂
Wi−1 (α) Ri (ρ)
m ∂α
i in group g

m
1 X ∂
=φ
W −1 (α) Ri (ρ).
m i=1 ∂α i

Next, using arguments similar to those given in Theorem 3.2 of Chaganty
and Shults (1999), we note that the stage one estimating equation (12) can
be expressed as
Ã
trace

!
m
1X ∂
0
W −1 (α)Zi (β̂)Zi (β̂) = 0.
m i=1 ∂α i

(B.1)

p

Because β̂ −→ β, even under misspecification of the true correlation
m
m
P
P
p
0
∂
∂
Wi−1 (α)Zi (β)Zi (β) −→ φ m1 ∂α
Wi−1 (α)Ri (ρ), it folstructure, and m1 ∂α
lows that

m
P
1
m

i=1

i=1

0

∂
Wi−1 (α)Zi (β̂)Zi (β̂)
∂α

p

m
P
1

−→ φ m

i=1

i=1

∂
Wi−1 (α)Ri (ρ).
∂α

The solution

α̂ to (B.1) therefore converges in probability to the solution g(ρ) of the following equation, as m → ∞:
Ã m
!
X ∂
−1
trace
W (α)Ri (ρ) = 0.
∂α i
i=1

(B.2)

Assume that the stage two estimate, which is the solution to (13), can be
p

p

expressed as f (α̂). Since α̂ → g(ρ), it follows that f (α̂) → f (g(ρ)).
We will now consider two special cases:
(i) When the True Structure is AR(1) but the Correlation Parameter is
Incorrectly Assumed to be Equal Across Groups: Let wg be the proportion of
subjects in group g and assume that ni = n ∀ i. Without loss of generality
assume that we have two groups of subjects, so that wA + wB = 1. The true
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correlation structure for subjects in groups A and B are R(ρA ) and R(ρB )
respectively, where R(ρA ) is an AR(1) structure with parameter ρA . The
correlation parameters are incorrectly assumed to be equal across groups, so
that the working structure is AR(1) structure, W (α). Equation (B.2) can
then be simplified as follows:
Ã
!
X ∂
X ∂
trace
W −1 (α)R(ρA ) +
W −1 (α)R(ρB ) = 0 =⇒
∂α
∂α
i ∈ grp A
i ∈ grp B
µ
trace

¶
∂
−1
W (α) [wA R(ρA ) + wB R(ρB )] = 0.
∂α

(B.3)

Because W −1 (α) is a tri-diagonal matrix for an AR(1) structure, only the
diagonal and off-diagonal elements of wA R(ρA ) + wB R(ρB ) are involved in
the solution of (B.3); the diagonal elements are wA + wB = 1 and the offdiagonal elements are wA ρA + wB ρB . The solution to (B.3) can be simplified
as follows; also see (3.11) of Chaganty and Shults (1999):

α =

2f (ρA , ρB )
,
1 + f (ρA , ρB )2

(B.4)

where



f (ρA , ρB ) =




√

1−

0

1−(wA ρA +wB ρB )2
wA ρA +wB ρB

if wA ρA + wB ρB 6= 0

(B.5)

if wA ρA + wB ρB = 0
p

Because the stage one estimate α̂ → f (ρA , ρB ) in probability, the stage
two estimate 2α̂/(1 + α̂2 ) for a working AR(1) structure therefore converges
to 2f (ρA , ρB )/(1 + f (ρA , ρB )2 ) = wA ρA + wB ρB in probability, as m → ∞.
For GEE, if we divide the numerator and denominator of (10) by m
it is straightforward to show that the numerator converges in probability
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to wA n (n − 1) φ ρA + wB n (n − 1) φ ρB , while the denominator converges
in probability to n (n − 1) φ, where φ = 1 for our model. As a result,
p

α̂GEE−EQC −→ wA ρA + wB ρB .
(ii) When the true AR(1) structure is misspecified as EQC: For an EQC
1
α
ei e0i , where Ini is
structure Wi−1 (α) =
Ini −
(1 − α)
(1 − α)(1 + (ni − 1)α)
the identity matrix and ei is a ni × 1 vector of ones. If we note that
Pni Pni |j−k|
trace(ei e0i Ri (ρ)) = trace(e0i Ri (ρ)ei ) =
when Ri (ρ) is an
j=1
k=1 ρ
ni × ni AR(1) structure, then it is easy to show that (B.2) can be simplified
as:
m
X
i=1

ni
ni X
m
X
1 + α2 (ni − 1) X
ρ|j−k| = 0.
ni −
2
(1 + α(ni − 1)) j=1 k=1
i=1

(B.6)

In general, a solution g(ρ) to (B.6) can be obtained using the bisection
p

p

method. Since α̂ → g(ρ), it follows that f (α̂) → f (g(ρ)), where f (g(ρ))
is obtained by evaluating (17) at g(ρ). This can be accomplished in the
following algorithm:
Algorithm to obtain limiting value of α̂QLS−EQC when the true AR(1)
structure is misspecified as EQC
(i) Use the method of bisection to obtain the solution α = g(ρ) to equation
(B.6).
(ii) Obtain the limit of α̂QLS−EQC by evaluating (17) at α
b = g(ρ).
When ni = n ∀ i the limiting values for α̂QLS−EQC and α̂GEE−EQC are
identical and are given by:
2

Pn−1 Pn
j=1

k=j+1

(n − 1)n

ρk−j

0

e R (ρ) en − n
= n
.
(n − 1)n

(B.7)
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To prove this, note that the limiting value of α̂QLS−EQC is the solution to the
stage two estimating equation, evaluated at δ that (when substituted for α)
satisfies the limiting value of the stage one estimating equation, i.e. we need
to show that (B.7) (substituted for α) satisfies (13), when (13) is evaluated
at δ that (when substituted for α) satisfies (B.6). To show this, we first note
that for balanced data when ni = n, (B.6) can be expressed as

n−

1 + α2 (n − 1) 0
en R(ρ) en = 0.
(1 + α(n − 1))2

(B.8)

For an EQC working structure with ni = n ∀ i, (13) can be expressed as

n−

1 + δ 2 (n − 1)
[n + n (n − 1) α] = 0.
(1 + δ(n − 1))2

(B.9)

If we substitute (B.7) for α in (B.9) and then let δ = α, we easily obtain
the left-hand side of (B.6). Therefore it is clear that (B.7) does indeed satisfy
(13) when (13) is evaluated at α that satisfies (B.6). The proof is therefore
P
(n−i)ρi
complete. We also note that (B.7) can also be expressed as ni=1 2n(n−1)
which was shown in Wang and Carey (2003) to be the limiting value for the
moment estimate α̂GEE−EQC , so that the limiting values agree for QLS and
GEE, when ni = n.

Appendix C
An algorithm to Obtain a Feasible (EBB) Estimate α̂
Without loss of generality we assume the working structure for subject i is
Wi (α), where Wi (α) is AR(1). First fit unadjusted GEE or QLS to obtain
β̂, α̂ and the feasible region (EBB) (L̂AR1 , ÛAR1 ) for α given in (8). If α̂ is
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infeasible (EBB) because α̂ > UAR1 then do the following. Set a tolerance
level, e.g. tolerance = 0.00001. Let count = 1; j = 1; and upper = α̂.
Step One: Let α̂ = upper −

1 count
10

× j.

Step Two: Update the estimate β̂ of β by solving the GEE estimating
equation evaluated at Wi (α̂). Update the estimates of feasible region (EBB)
in (8) and check if α̂ is feasible (EBB), i.e. if L̂AR1 ≤ α̂ ≤ ÛAR1 ). If
α̂ > ÛAR1 then let j = j + 1 and repeat steps one and two. If L̂AR1 ≤ α̂ ≤
ÛAR1 but tolerance <

1 count
,
10

then let upper = α̂ +

1 count
;
10

then j = 1;

count = count + 1; and repeat steps one and two. If L̂AR1 ≤ α̂ ≤ ÛAR1
and tolerance ≥

1 count
,
10

then the process is done and the adjusted estimate

α̂ADJ will be given by α̂.
If α̂ is infeasible (EBB) because α̂ < L̂AR1 then the above algorithm
can be applied, for lower = α̂, α̂ = lower +
α̂ −

1 count
10

1 count
10

× j and lower =

substituted for their corresponding values for upper in steps one

and two, respectively. For other working structures, the above algorithm can
be applied but must be based on the feasible region (EBB) (for α) for that
particular structure. For example, for the EQC structure the above approach
will be based on the feasible region (EBB) (L̂EQC , ÛEQC ) given in (7).
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Figure 1. Proportion of infeasible (EBB) estimates versus the true correlation for GEE;
β =(0.6707, 0.4753, −0.2273, −0.2850)0 ; the true correlation structure is correctly specified
as AR(1) with ni = 3 ∀ i (left); ni = 8 ∀ i (right); and the number of subjects per group is
m = 10, 20, 40, 60, and 80.
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Figure 2. Proportion of infeasible (EBB) estimates of α̂QLS versus ρV when the
correlation is incorrectly assumed to be equal in the treatment groups; ρL = 0.85; β =
(0.6707, 0.4753, −0.2273, −0.2850)0 ; the true correlation structure is AR(1) with ni = 8
∀ i; and the number of subjects per group is m = 10, 20, 30, 60, and 120.

41

Hosted by The Berkeley Electronic Press

.6
.4
.2
0

Limit
Upper Bound
0

.2

.4
True Correlation

.6

.8

Figure 3. Limiting value of α̂QLS versus the true correlation when the AR(1) structure
is misspecified as EQC in the Venlafoxine Study; the upper bound in (LEQC , UEQC ) is
displayed as a horizontal line.
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Table 1
Simulation Results
m

Design
n α

GEE

Bias
QLS
IND

MID

GEE

MSE
QLS
IND

MID

Estimation of α
10
20
30
60
80

8
8
8
8
8

.6
.6
.6
.6
.6

-0.0461
-0.0209
-0.0113
-0.0049
-0.0032

-0.0479
-0.0218
-0.0120
-0.0051
-0.0034

-0.6000
-0.6000
-0.6000
-0.6000
-0.6000

-0.5597
-0.5531
-0.5518
-0.5508
-0.5508

0.0114
0.0050
0.0027
0.0013
0.0009

0.0114
0.0050
0.0027
0.0013
0.0009

0.3600
0.3600
0.3600
0.3600
0.3600

0.3141
0.3065
0.3049
0.3035
0.3035

0.0110
0.0030
0.0016
0.0007
0.0005

0.0111
0.0030
0.0016
0.0007
0.0005

0.5625
0.5625
0.5625
0.5625
0.5625

0.5080
0.5003
0.4946
0.4934
0.4922

0.0054
0.0027
0.0022
0.0014
0.0013

0.0055
0.0028
0.0023
0.0014
0.0013

0.0096
0.0070
0.0064
0.0052
0.0052

0.0099
0.0072
0.0064
0.0052
0.0052

Estimation of α
10
20
30
60
80

8
8
8
8
8

.75
.75
.75
.75
.75

-0.0202
-0.0192
-0.0084
-0.0044
-0.0027

-0.0231
-0.0208
-0.0094
-0.0048
-0.0030

-0.7500
-0.7500
-0.7500
-0.7500
-0.7500

-0.7121
-0.7070
-0.7030
-0.7023
-0.7014

Estimation of P (Yi4 = 1, Yi8 = 1) for Lithium group
10
20
30
60
80

8
8
8
8
8

.6
.6
.6
.6
.6

0.0034
0.0033
0.0009
0.0037
0.0018

0.0030
0.0031
0.0008
0.0036
0.0017

-0.0191
-0.0220
-0.0251
-0.0235
-0.0254

-0.0186
-0.0219
-0.0248
-0.0235
-0.0255

0.0060
0.0028
0.0019
0.0011
0.0007

0.0059
0.0028
0.0019
0.0011
0.0007

Estimation of P (Yi4 = 1, Yi8 = 1) for Lithium group
10
20
30
60
80

8
8
8
8
8

.75
.75
.75
.75
.75

-0.0014
-0.0021
-0.0014
0.0008
-0.0000

-0.0025
-0.0026
-0.0018
0.0007
-0.0001

-0.0558
-0.0622
-0.0650
-0.0647
-0.0659

-0.0550
-0.0615
-0.0642
-0.0644
-0.0659

0.0090
0.0047
0.0033
0.0016
0.0013

0.0089
0.0047
0.0033
0.0016
0.0013
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Table 2
Analysis of Venlafaxine versus Lithium: α̂ and bounds (EBB); Rotnizky-Jewell informal goodness
of fit measures (c1 , c2 , and d); and estimated regression parameters with standard errors (Std.Err.)
and p-values for the tests of Ho : βj = 0; P (0, 1)V en and P (0, 1)Lithium = P (Yi4 = 0, Yi8 = 1)
for subjects treated with Venlafaxine and Lithium, respectively; Approaches used include GEE
with EQC (GEE/EQC) or AR(1) (GEE/AR(1)) structures; QLS with EQC (QLS/EQC) or
AR(1) (QLS/AR(1)) structures; and GEE with working independence (IND).
QLS/EQC

GEE/EQC

QLS/AR(1)

GEE/AR(1)

GEE/IND

α̂
Bounds (EBB)

0.4177
(-.0475,.1674)

0.4013
(-.0489,.1686)

0.5678
(-.0674,.7740)

0.5684
(-.0674,.7740)

0
NA

c1
c2
d

1.8074
4.4756
1.8608

1.7756
4.2321
1.6810

1.1719
1.5907
0.2468

1.1712
1.5886
0.2461

2.5723
8.2379
4.0933

gof

NA

NA

159.11

159.12

313.88

β̂0
Std.Err.(β̂0 )
p − value

0.6875
0.4224
0.104

0.6884
0.4227
0.103

0.6707
0.4205
0.111

0.6708
0.4205
0.111

0.6589
0.4489
0.142

β̂1
Std.Err.(β̂1 )
p − value

0.0962
0.6365
0.880

0.1086
0.6320
0.864

0.4753
0.5971
0.426

0.4755
0.5971
0.426

0.3233
0.6042
0.593

β̂2
Std.Err.(β̂2 )
p − value

-0.2686
0.0929
0.004

-0.2680
0.0928
0.004

-0.2273
0.0892
0.011

-0.2273
0.0892
0.011

-0.2381
0.1025
0.020

β̂3
Std.Err.(β̂3 )
p − value

-0.2421
0.1879
0.198

-0.2407
0.1860
0.196

-0.2850
0.1672
0.088

-0.2850
0.1672
0.088

-0.2469
0.1679
0.141

P̂ (0, 1)V en
P̂ (0, 1)Lithium

-0.0044
0.0320

-0.0031
0.0353

0.0251
0.1127

0.0250
0.1126

0.0378
0.1280
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